Event

The Department of Pediatrics at Cooperman Barnabas Medical Center presents: RWJBarnabas Health Children’s Kidney Center Annual Symposium - Prevention & Treatment of Kidney Disease in Children

Date and Time:
October 16, 2025 | 5:00 pm to 7:00 pm

Location:
Cooperman Barnabas Medical Center - Islami Auditorium
94 Old Short Hills Road, Livingston, NJ 07039

Early recognition and treatment of renal disorders in children can delay progression and may even prevent the development of chronic renal failure, minimizing neurological deficits and growth retardation. Recent technological breakthroughs and better understanding of pediatric kidney disease has led to improved care of infants and children with various nephropathies.

This program is designed to provide an update for pediatricians, pediatric urologists, pediatric subspecialists and nurses regarding renal disease from the neonatal period to late adolescence.

Symposium Agenda:

• 5:00 pm Welcome - Isabel Roberti, MD, PhD
• 5:05 pm Immune System and Kidney Cross Talk - Marla Guzman, MD
• 5:30 pm Challenging Journey from Chronic Kidney Disease to Transplantation - Shefali Vyas, MD
• 5:55 pm Boney Issues in Kidney Disease - Neil Kaushal, MD
• 6:20 pm New Therapeutic Advances in Kidney Disease - Rachel Meyers, PharmD
• 6:45 pm Closing Program Evaluation
• 6:50 pm Exhibitor Lounge

AMA Credit Designation Statement
Cooperman Barnabas Medical Center designates this live activity for a maximum of AMA PRA Category 2 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement (for Directly provided)
Cooperman Barnabas Medical Center is accredited by the Medical Society of New Jersey (MSNJ) to provide continuing education for physicians.

Disclosure Policy
It is the policy of Cooperman Barnabas Medical Center, Office of Continuing Medical Education to ensure balance, independence, transparency, objectivity, and scientific rigor in all CME sponsored education activities. All participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict(s) of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussion of unlabeled or unapproved drugs or devices. This information will be available as part of the activity material.

Faculty Disclosures
No relevant financial relationship(s) or disclose any relationship(s) that exist.

Acknowledgement of Commercial Support
No commercial support was provided for the live activity or State any commercial support “Patient Safety Committee Work Product – Confi dential Protection and Restrictions on Disclosure Pursuant to N.J.S.A. 26:2H – 12.25b. & N.J.A.C. 8:43E – 10.”